Ken Yoshida（Kinki/Osaka）
Associate Professor
We have been enhancing the precision of high-dose-rate (HDR) interstitial brachytherapy. We also provide treatment for sites generally considered difficult to treat, if deemed feasible. In addition to curative treatment, we are also engaged in palliative therapy.
- Clinical department/Main areas of expertise
- Specialized area
-
- Interstitial Brachytherapy for Cancer
Target diseases: Gynecological cancers, prostate cancer, head and neck cancers, breast cancer, bone and soft tissue tumors, rectal and anal cancer, others. Detail
- Interstitial Brachytherapy for Cancer
- surgery
- Interstitial Brachytherapy for Cancer
Target diseases: Gynecological cancers, prostate cancer, head and neck cancers, breast cancer, bone and soft tissue tumors, rectal and anal cancer, others.
- Qualifications/Academia/Position
-
- Board Certified Radiation Oncologist
- Japanese Society for Radiation Oncology (JASTRO)
- Japan Radiological Society (JRS)
- Japan Society for Head and Neck Cancer
- Japanese Society for Palliative Medicine (JSPM)
- Delegate, Japanese Society for Radiation Oncology (JASTRO)
- Secretary, Brachytherapy Committee, Japanese Society for Radiation Oncology (JASTRO)
- Affiliated hospital
- Kansai Medical University Medical Center
- Website
- https://hp.kmu.ac.jp/takii/
- location
-
〒570-8507
10-15 Fumizono-cho, City of Moriguchi, Google Map Map
- Biography
-
- 1994
- Graduated from Kobe University School of Medicine
- 1994
- Resident, Department of Radiology, Osaka University Hospital
- 1995
- Trainee, Fifth Department of Internal Medicine, Osaka Prefectural Adult Disease Center
- 2000
- Obtained degree, Graduate School of Medicine (Radiation Oncology), Osaka University
- 2000
- Department of Radiology (currently Department of Radiation Oncology), National Osaka Hospital (now National Hospital Organization Osaka National Hospital)
- 2011
- Concurrently served as Director, Advanced Medical Technology Development Office, EBM Research and Development Department, Clinical Research Center, same hospital
- 2012
- Lecturer, Department of Radiology, Osaka Medical University (Associate Professor since 2020)
- 2020
- Associate Professor, Department of Radiology, Kansai Medical University General Medical Center
- paper
-
- Combined external radiotherapy and single-fraction palliative high-dose-rate interstitial brachytherapy for a patient with a base of tongue cancer who had a previous radiation history. Oral Radiol. 2025;41:144-150.
- Single-Fraction Palliative High-Dose-Rate Brachytherapy for Symptom Management in a 97-Year-Old Patient With Dementia. J Palliat Med. 2024;27:1102-6.
- HDR-brachytherapy for accelerated partial breast irradiation: Long-term experience from a Japanese institution. J Contemp Brachytherapy 2023;15:1-8.
- Edema worsens target coverage in high-dose-rate interstitial brachytherapy of mobile tongue cancer: a report of two cases. J Contemp Brachytherapy 2017;9:66-70.
- Simulation analysis of optimized brachytherapy for uterine cervical cancer: Can we select the best brachytherapy modality depending on tumor size? Brachytherapy. 2016;15:57-64
- Role of vaginal pallor reaction in predicting late vaginal stenosis after high-dose-rate brachytherapy in treatment-naive patients with cervical cancer. J Gynecol Oncol. 2015;26:179-84.
- "Treatment results of image-guided high-dose-rate interstitial brachytherapy for pelvic recurrence of uterine cancer. " Brachytherapy. 2015;14:440-8.
- "Preliminary results of MRI-assisted high-dose-rate interstitial brachytherapy for uterine cervical cancer. " Brachytherapy. 2015;14:1-8.
- Longitudinal analysis of late vaginal mucosal reactions after high-dose-rate brachytherapy in patients with gynecological cancer. Anticancer Res 2014;34:4433-8.
- Role of novel risk classification method, Prostate Cancer Risk Index (PRIX) for clinically localized prostate cancer after high-dose-rate interstitial brachytherapy as monotherapy. Anticancer Res 2014;34:3077-81.